XSHE
000615
Market cap442mUSD
Oct 09, Last price
3.19CNY
1D
-0.31%
1Q
0.63%
Jan 2017
-69.30%
Name
Aoyuan Beauty Valley Technology Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jointown Aesthetics Valley Co., Ltd. is a provider of crucial technologies, specialized materials, and diverse services for the global beauty and health industries, with operations spanning both China and international markets. The company's business is structured across three main divisions: Chemical Fiber, Medical Beauty, and Warehousing. Its product offerings include the manufacture and sale of items such as lyocell fiber, viscose filament, glassine, chemical fiber pulp, and refined cotton. Furthermore, the company extends its services to include property administration and storage solutions. Originally founded in 1993, the firm's corporate identity was updated in February 2026, when it changed its name from Aoyuan Beauty Valley Technology Co.,Ltd. to its current designation, Jointown Aesthetics Valley Co., Ltd. Its primary administrative center is situated in Guangzhou, China.
Key people
Tao Liu
Chairman of the Board · since 2024
Song Yun
Vice President · since 2023
Zhen Zhang
Vice President · since 2023
Jianwei Zhang
Secretary of the Board, Director · since 2023
Jun Ban
Director · since 2020
Shijie Fan
President, Staff Elected Director · since 2020
Shiguo Guo
Director · since 2024
Yongbiao Jiang
Chief Financial Officer, Director · since 2023
Chunxia Leng
Director · since 2026
Dongyang Li
Director · since 2026
Liang Liu
Director · since 2026
Xiling Su
Director · since 2026
Dahong Liu
Independent Director · since 2026
Ruying Liu
Independent Director · since 2024
Yan Peng
Independent Director · since 2026
Yonghai Qu
Independent Director · since 2020
Jiaming Sun
Independent Director · since 2026
Tanneng Yang
Independent Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||